UK Introduces 'World-First' Law Enabling Point-Of-Care Manufacture of Personalised Medicines
Introduced by the Medicines and Healthcare products Regulatory Agency (MHRA), the new legislation allows personalised medicines to be prepared in small or individual batches right where patients are treated.
Personalised Medicines | 24/07/2025 | By Dineshwori
Global API Market Expected to Reach USD 422.8 Billion by 2034
The global Active Pharmaceutical Ingredients (API) market is projected to grow at a compound annual growth rate (CAGR) of 6.7 percent to an estimated USD 422.8 billion by 2034, according to a report.
Personalised Medicines | 09/07/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy